Axsome Therapeutics, Inc.
AXSM
Rank in Stocks
#2338
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to... Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.
Share Price
$160.25
Market Cap
$8.39B
Change (1 day)
2.85%
Change (1 year)
21.77%
Country
US
Trade Axsome Therapeutics, Inc. (AXSM)
Category
Healthcare
Stock split history for Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. stock (symbol: AXSM) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One AXSM share bought prior to Oct 20, 2026 would equal to 0 AXSM shares today.
The most recent stock split occurred on Oct 20, 2026.
One AXSM share bought prior to Oct 20, 2026 would equal to 0 AXSM shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
